Commercial Channels

Latest News

LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim
LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim

July 14th 2025

The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and potentially, other IL-36–driven conditions.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey
Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

July 10th 2025

Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry

July 2nd 2025

Discovering AI’s Role in Drug Safety Monitoring
Discovering AI’s Role in Drug Safety Monitoring

June 27th 2025

Conference Connect: Determining the Future of Specialty Pharmacy
Conference Connect: Determining the Future of Specialty Pharmacy

June 18th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.